REDCARE PHARMACY INH./ NL0012044747 /
| 16/11/2024 13:04:01 | Chg. 0.00 | Volume | Bid13:04:01 | Ask13:04:01 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 151.50EUR | 0.00% | - Turnover: - |
151.50Bid Size: - | 152.30Ask Size: - | 2.91 bill.EUR | - | - |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 13.2000 | 74.5000 | 78.3000 | 85.4400 | 52.2000 | ||||||
| Intangible Assets | 199.9000 | 204.7000 | 257.5000 | 289.0100 | 428.1000 | ||||||
| Long-Term Investments | 2.5000 | 1.7000 | 13.1000 | 1.2700 | 4.8000 | ||||||
| Fixed Assets | - | - | - | 385.5600 | 522.1000 | ||||||
| Inventories | 56.7000 | 81.2000 | 96.6000 | 99.7100 | 135.8000 | ||||||
| Accounts Receivable | 40.9000 | 44.6000 | 52.3000 | 59.8800 | 103.1000 | ||||||
| Cash and Cash Equivalents | 62.7000 | 90.5000 | 247.4000 | 66.7800 | 84.2000 | ||||||
| Current Assets | 210.8000 | 254.1000 | 432.8000 | 343.9200 | 499.5000 | ||||||
| Total Assets | 428 | 536.9000 | 783.1000 | 729.4700 | 1,021.6000 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 32 | 53.1000 | 80.5000 | 72.8800 | 157.6000 | ||||||
| Long-term debt | - | - | - | 247.6500 | 236.1000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 3.9000 | 4.3000 | 13.6000 | 7.8900 | 6.3000 | ||||||
| Liabilities | 195.2000 | 111.8000 | 367.7000 | 729.4700 | 469.6000 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | 232.8000 | 425.1000 | 415.4000 | 354.6300 | 522.2000 | ||||||
| Minority Interests | - | - | - | - | 29.8000 | ||||||
| Total liabilities equity | 428 | 536.9000 | 783.1000 | 729.4700 | 1,021.6000 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 701 | 968.1000 | 1,060.3000 | 1,204.3500 | 1,798.8000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -33.4000 | -.9000 | -65.7000 | -69.1700 | -17.3000 | ||||||
| Interest Income | -8.9000 | -15.1100 | -11.8000 | -15.2800 | 2.7000 | ||||||
| Income Before Taxes | -42.2000 | -15.9000 | -77.9000 | - | - | ||||||
| Income Taxes | -5.9000 | .8000 | 3.7000 | -6.4700 | 2.7000 | ||||||
| Minority Interests Profit | - | - | - | - | -.4000 | ||||||
| Net Income | -36.3000 | -16.8000 | -74.2000 | -77.6500 | -11.6000 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -30.4000 | 17.8000 | 11.6000 | -29.1100 | 61.5000 | ||||||
| Cash Flow from Investing Activities | -33.4000 | -40.3000 | -84.3000 | -138.0100 | -60 | ||||||
| Cash Flow from Financing | 102.1000 | 50.3000 | 229.6000 | -13.5200 | 15 | ||||||
| Decrease / Increase in Cash | 38.3000 | 27.8000 | 156.9000 | - | - | ||||||
| Employees | 1,011 | 1,220 | 1,826 | 2,164 | 2,075 | ||||||
